Do analysts prefer ITH or HCM?

Ithaca Energy currently has a consensus price target of GBX 226.67, indicating a potential downside of 1.28%. Given Ithaca Energy's stronger consensus rating and higher probable upside, analysts clearly believe Ithaca Energy is more favorable than HUTCHMED. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ithaca Energy 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 HUTCHMED 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, ITH or HCM?

Ithaca Energy has higher revenue and earnings than HUTCHMED. Ithaca Energy is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ithaca Energy £2.95B 1.29 £230.29M -£5.10 N/A HUTCHMED £548.51M 2.69 -£52.98M £53.00 3.24

Does the media prefer ITH or HCM?

In the previous week, Ithaca Energy had 8 more articles in the media than HUTCHMED. MarketBeat recorded 10 mentions for Ithaca Energy and 2 mentions for HUTCHMED. Ithaca Energy's average media sentiment score of 1.14 beat HUTCHMED's score of -0.40 indicating that Ithaca Energy is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ithaca Energy 4 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HUTCHMED 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, INDV or HCM?

Indivior has higher revenue and earnings than HUTCHMED. Indivior is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Indivior £1.40B 1.38 -£2.36M -£1.21 N/A HUTCHMED £548.51M 2.69 -£52.98M £53.00 3.24

Is INDV or HCM more profitable?

HUTCHMED has a net margin of 163.84% compared to Indivior's net margin of 11.44%. HUTCHMED's return on equity of 36.88% beat Indivior's return on equity. Company Net Margins Return on Equity Return on Assets Indivior 11.44% -23.90% 2.37% HUTCHMED 163.84% 36.88% -5.90%

Do analysts rate HCM or GRI?

Grainger has a consensus target price of GBX 225.60, indicating a potential upside of 29.06%. Given Grainger's stronger consensus rating and higher probable upside, analysts clearly believe Grainger is more favorable than HUTCHMED. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HUTCHMED 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Grainger 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80

Which has preferable valuation & earnings, HCM or GRI?

Grainger has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Grainger, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HUTCHMED £548.51M 2.69 -£52.98M £53.00 3.24 Grainger £238.20M 5.42 -£1.11M £27.30 6.40

Is HCM or GRI more profitable?

HUTCHMED has a net margin of 163.84% compared to Grainger's net margin of 54.91%. HUTCHMED's return on equity of 36.88% beat Grainger's return on equity. Company Net Margins Return on Equity Return on Assets HUTCHMED 163.84% 36.88% -5.90% Grainger 54.91% 6.53% 2.14%

Does the media favor HCM or GRI?

In the previous week, Grainger had 5 more articles in the media than HUTCHMED. MarketBeat recorded 7 mentions for Grainger and 2 mentions for HUTCHMED. Grainger's average media sentiment score of 1.46 beat HUTCHMED's score of -0.40 indicating that Grainger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HUTCHMED 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Grainger 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

HUTCHMED (HCM) Competitors

GBX 171.50 +6.50 (+3.94%)

As of 11:53 AM Eastern

Compare

HCM vs. ITH, SOPH, INDV, GRI, and SLS

Should you buy HUTCHMED stock or one of its competitors? MarketBeat compares HUTCHMED with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with HUTCHMED include Ithaca Energy (ITH), Sophos Group plc (SOPH.L) (SOPH), Indivior (INDV), Grainger (GRI), and Standard Life UK Smaller Companies Trust (SLS). These companies are all part of the "pharmaceutical products" industry.

How does HUTCHMED compare to Ithaca Energy?

Ithaca Energy (LON:ITH) and HUTCHMED (LON:HCM) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

In the previous week, Ithaca Energy had 8 more articles in the media than HUTCHMED. MarketBeat recorded 10 mentions for Ithaca Energy and 2 mentions for HUTCHMED. Ithaca Energy's average media sentiment score of 1.14 beat HUTCHMED's score of -0.40 indicating that Ithaca Energy is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ithaca Energy	4 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HUTCHMED	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

4.0% of Ithaca Energy shares are owned by institutional investors. Comparatively, 20.4% of HUTCHMED shares are owned by institutional investors. 0.2% of Ithaca Energy shares are owned by company insiders. Comparatively, 2.8% of HUTCHMED shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Ithaca Energy has higher revenue and earnings than HUTCHMED. Ithaca Energy is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ithaca Energy	£2.95B	1.29	£230.29M	-£5.10	N/A
HUTCHMED	£548.51M	2.69	-£52.98M	£53.00	3.24

Ithaca Energy has a beta of 0.313, meaning that its stock price is 69% less volatile than the broader market. Comparatively, HUTCHMED has a beta of 0.428, meaning that its stock price is 57% less volatile than the broader market.

HUTCHMED has a net margin of 163.84% compared to Ithaca Energy's net margin of 7.53%. HUTCHMED's return on equity of 36.88% beat Ithaca Energy's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ithaca Energy	7.53%	9.33%	0.18%
HUTCHMED	163.84%	36.88%	-5.90%

Ithaca Energy currently has a consensus price target of GBX 226.67, indicating a potential downside of 1.28%. Given Ithaca Energy's stronger consensus rating and higher probable upside, analysts clearly believe Ithaca Energy is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ithaca Energy	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Ithaca Energy and HUTCHMED tied by winning 8 of the 16 factors compared between the two stocks.

How does HUTCHMED compare to Sophos Group plc (SOPH.L)?

HUTCHMED (LON:HCM) and Sophos Group plc (SOPH.L) (LON:SOPH) are both pharmaceutical products companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Sophos Group plc (SOPH.L) has higher revenue and earnings than HUTCHMED. Sophos Group plc (SOPH.L) is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.69	-£52.98M	£53.00	3.24
Sophos Group plc (SOPH.L)	£726.90M	0.00	N/A	£1.70	N/A

20.4% of HUTCHMED shares are owned by institutional investors. 2.8% of HUTCHMED shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, HUTCHMED had 2 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Sophos Group plc (SOPH.L). Sophos Group plc (SOPH.L)'s average media sentiment score of 0.00 beat HUTCHMED's score of -0.40 indicating that Sophos Group plc (SOPH.L) is being referred to more favorably in the news media.

Company	Overall Sentiment
HUTCHMED	Neutral
Sophos Group plc (SOPH.L)	Neutral

HUTCHMED has a net margin of 163.84% compared to Sophos Group plc (SOPH.L)'s net margin of 0.00%. HUTCHMED's return on equity of 36.88% beat Sophos Group plc (SOPH.L)'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	163.84%	36.88%	-5.90%
Sophos Group plc (SOPH.L)	N/A	N/A	N/A

Summary

HUTCHMED beats Sophos Group plc (SOPH.L) on 6 of the 10 factors compared between the two stocks.

How does HUTCHMED compare to Indivior?

Indivior (LON:INDV) and HUTCHMED (LON:HCM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

86.0% of Indivior shares are owned by institutional investors. Comparatively, 20.4% of HUTCHMED shares are owned by institutional investors. 3.4% of Indivior shares are owned by insiders. Comparatively, 2.8% of HUTCHMED shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Indivior has higher revenue and earnings than HUTCHMED. Indivior is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Indivior	£1.40B	1.38	-£2.36M	-£1.21	N/A
HUTCHMED	£548.51M	2.69	-£52.98M	£53.00	3.24

Indivior has a beta of 0.19, indicating that its share price is 81% less volatile than the broader market. Comparatively, HUTCHMED has a beta of 0.428, indicating that its share price is 57% less volatile than the broader market.

In the previous week, HUTCHMED had 2 more articles in the media than Indivior. MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Indivior. Indivior's average media sentiment score of 0.00 beat HUTCHMED's score of -0.40 indicating that Indivior is being referred to more favorably in the media.

Company	Overall Sentiment
Indivior	Neutral
HUTCHMED	Neutral

HUTCHMED has a net margin of 163.84% compared to Indivior's net margin of 11.44%. HUTCHMED's return on equity of 36.88% beat Indivior's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Indivior	11.44%	-23.90%	2.37%
HUTCHMED	163.84%	36.88%	-5.90%

Summary

HUTCHMED beats Indivior on 7 of the 13 factors compared between the two stocks.

How does HUTCHMED compare to Grainger?

HUTCHMED (LON:HCM) and Grainger (LON:GRI) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

Grainger has lower revenue, but higher earnings than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Grainger, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HUTCHMED	£548.51M	2.69	-£52.98M	£53.00	3.24
Grainger	£238.20M	5.42	-£1.11M	£27.30	6.40

HUTCHMED has a beta of 0.428, meaning that its share price is 57% less volatile than the broader market. Comparatively, Grainger has a beta of 0.777, meaning that its share price is 22% less volatile than the broader market.

In the previous week, Grainger had 5 more articles in the media than HUTCHMED. MarketBeat recorded 7 mentions for Grainger and 2 mentions for HUTCHMED. Grainger's average media sentiment score of 1.46 beat HUTCHMED's score of -0.40 indicating that Grainger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HUTCHMED	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Grainger	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

20.4% of HUTCHMED shares are held by institutional investors. Comparatively, 48.1% of Grainger shares are held by institutional investors. 2.8% of HUTCHMED shares are held by insiders. Comparatively, 1.5% of Grainger shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

HUTCHMED has a net margin of 163.84% compared to Grainger's net margin of 54.91%. HUTCHMED's return on equity of 36.88% beat Grainger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HUTCHMED	163.84%	36.88%	-5.90%
Grainger	54.91%	6.53%	2.14%

Grainger has a consensus target price of GBX 225.60, indicating a potential upside of 29.06%. Given Grainger's stronger consensus rating and higher probable upside, analysts clearly believe Grainger is more favorable than HUTCHMED.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HUTCHMED	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Grainger	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Summary

Grainger beats HUTCHMED on 11 of the 16 factors compared between the two stocks.

How does HUTCHMED compare to Standard Life UK Smaller Companies Trust?

Standard Life UK Smaller Companies Trust (LON:SLS) and HUTCHMED (LON:HCM) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

In the previous week, HUTCHMED had 2 more articles in the media than Standard Life UK Smaller Companies Trust. MarketBeat recorded 2 mentions for HUTCHMED and 0 mentions for Standard Life UK Smaller Companies Trust. Standard Life UK Smaller Companies Trust's average media sentiment score of 0.00 beat HUTCHMED's score of -0.40 indicating that Standard Life UK Smaller Companies Trust is being referred to more favorably in the media.

Company	Overall Sentiment
Standard Life UK Smaller Companies Trust	Neutral
HUTCHMED	Neutral

20.4% of HUTCHMED shares are held by institutional investors. 2.8% of HUTCHMED shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Standard Life UK Smaller Companies Trust has higher earnings, but lower revenue than HUTCHMED. Standard Life UK Smaller Companies Trust is trading at a lower price-to-earnings ratio than HUTCHMED, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard Life UK Smaller Companies Trust	£222.48M	0.00	N/A	£217.40	N/A
HUTCHMED	£548.51M	2.69	-£52.98M	£53.00	3.24

HUTCHMED has a net margin of 163.84% compared to Standard Life UK Smaller Companies Trust's net margin of 0.00%. HUTCHMED's return on equity of 36.88% beat Standard Life UK Smaller Companies Trust's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard Life UK Smaller Companies Trust	N/A	N/A	N/A
HUTCHMED	163.84%	36.88%	-5.90%

Summary

HUTCHMED beats Standard Life UK Smaller Companies Trust on 6 of the 10 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HCM vs. The Competition

Export

Metric	HUTCHMED	Drug Manufacturers Industry	Medical Sector	LON Exchange
Market Cap	£1.47B	£6.39B	£7.06B	£2.84B
Dividend Yield	4.63%	2.82%	2.68%	6.17%
P/E Ratio	3.24	5.03	27.15	368.18
Price / Sales	2.69	1,659.36	526.88	84,612.72
Price / Cash	2.49	10.18	29.22	27.87
Price / Book	1.96	10.90	10.75	7.49
Net Income	-£52.98M	£20.27B	£3.58B	£5.89B
7 Day Performance	-5.77%	-0.57%	-2.10%	-0.48%
1 Month Performance	3.94%	-1.21%	3.32%	-1.00%
1 Year Performance	-27.33%	8.85%	28.17%	61.74%

HUTCHMED Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HCM HUTCHMED	N/A	GBX 171.50 +3.9%	N/A	-30.1%	£1.47B	£548.51M	3.24	1,760
ITH Ithaca Energy	1.8846 of 5 stars	GBX 218.80 +0.5%	GBX 226.67 +3.6%	+33.5%	£3.61B	£2.95B	N/A	220
SOPH Sophos Group plc (SOPH.L)	N/A	N/A	N/A	N/A	£2.99B	£726.90M	341.41	520
INDV Indivior	N/A	GBX 1,238 +1.6%	N/A	+8.4%	£1.93B	£1.40B	N/A	1,000	Gap Up High Trading Volume
GRI Grainger	4.7324 of 5 stars	GBX 174.50 -1.0%	GBX 225.60 +29.3%	-15.7%	£1.29B	£238.20M	6.39	372	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:HCM) was last updated on 7/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HUTCHMED (HCM) Competitors

HCM vs. ITH, SOPH, INDV, GRI, and SLS

How does HUTCHMED compare to Ithaca Energy?

Summary

How does HUTCHMED compare to Sophos Group plc (SOPH.L)?

Summary

How does HUTCHMED compare to Indivior?

Summary

How does HUTCHMED compare to Grainger?

Summary

How does HUTCHMED compare to Standard Life UK Smaller Companies Trust?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCM vs. The Competition

HUTCHMED Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HUTCHMED (HCM) Competitors

HCM vs. ITH, SOPH, INDV, GRI, and SLS

How does HUTCHMED compare to Ithaca Energy?

Does the media prefer ITH or HCM?

Do insiders and institutionals have more ownership in ITH or HCM?

Which has stronger valuation & earnings, ITH or HCM?

Which has more volatility & risk, ITH or HCM?

Is ITH or HCM more profitable?

Do analysts prefer ITH or HCM?

Summary

How does HUTCHMED compare to Sophos Group plc (SOPH.L)?

Which has preferable earnings & valuation, HCM or SOPH?

Do insiders and institutionals have more ownership in HCM or SOPH?

Does the media favor HCM or SOPH?

Is HCM or SOPH more profitable?

Summary

How does HUTCHMED compare to Indivior?

Do insiders & institutionals have more ownership in INDV or HCM?

Which has better valuation & earnings, INDV or HCM?

Which has more volatility and risk, INDV or HCM?

Does the media refer more to INDV or HCM?

Is INDV or HCM more profitable?

Summary

How does HUTCHMED compare to Grainger?

Which has preferable valuation & earnings, HCM or GRI?

Which has more volatility & risk, HCM or GRI?

Does the media favor HCM or GRI?

Do institutionals & insiders hold more shares of HCM or GRI?

Is HCM or GRI more profitable?

Do analysts rate HCM or GRI?

Summary

How does HUTCHMED compare to Standard Life UK Smaller Companies Trust?

Does the media favor SLS or HCM?

Do institutionals & insiders have more ownership in SLS or HCM?

Which has stronger valuation & earnings, SLS or HCM?

Is SLS or HCM more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HCM vs. The Competition

HUTCHMED Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools